Skip to content

Clinical trials

Completed Phase 1 beta-Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Phase: Phase 1 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20091
20121
20141
20171
20191
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CorrectSequence Therapeutics Co., Ltd2
Beni-Suef University1
Celgene1
Children's Hospital of Fudan University1
Emory University1
FerroKin BioSciences, Inc.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Prolong Pharmaceuticals1
Shiraz University of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia10
Anemia, Sickle Cell4
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Chediak-Higashi Syndrome1
Dyskeratosis Congenita1
Fanconi Anemia1
Granulomatous Disease, Chronic1
Hemoglobin SC Disease1
Iron Overload1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.